Clinical Benefits of Azilsartan Beyond Blood Pressure Lowering? Takashi Kajiya EDITORIAL 24 June 2014 Pages: 293 - 294
Capsaicin-Induced Cardioprotection. Is Hypothermia or the Salvage Kinase Pathway Involved? Joan DowBoris Z. SimkhovichRobert A. Kloner ORIGINAL ARTICLE 18 May 2014 Pages: 295 - 301
MiR-132 Inhibits Expression of SIRT1 and Induces Pro-inflammatory Processes of Vascular Endothelial Inflammation through Blockade of the SREBP-1c Metabolic Pathway Liwei ZhangDangsheng HuangLuyue Gai ORIGINAL ARTICLE 13 June 2014 Pages: 303 - 311
Azilsartan Decreases Renal and Cardiovascular Injury in the Spontaneously Hypertensive Obese Rat Md. Abdul Hye KhanJan NeckářJohn D. Imig ORIGINAL ARTICLE 20 May 2014 Pages: 313 - 322
Laboratory Aspirin Resistance Reversibility in Diabetic Patients: a Pilot Study Using Different Pharmaceutical Formulations Roberto GrimaldiMarta BisiFiorenzo Gaita ORIGINAL ARTICLE 02 July 2014 Pages: 323 - 329
Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors: New among Antidiabetic Drugs L. H. Opie REVIEW ARTICLE 14 May 2014 Pages: 331 - 334
Renin-Angiotensin System Phenotyping as a Guidance Toward Personalized Medicine for ACE Inhibitors: can the Response to ACE Inhibition be Predicted on the Basis of Plasma Renin or ACE? Joyce E.M. SchildersHaiyan WuA.H. Jan Danser ORIGINAL ARTICLE 24 June 2014 Pages: 335 - 345
Thioredoxin-Interacting Protein: Pathophysiology and Emerging Pharmacotherapeutics in Cardiovascular Disease and Diabetes Cher-Rin ChongWai Ping A. ChanJohn D. Horowitz REVIEW ARTICLE 05 August 2014 Pages: 347 - 360
Lipid-lowering Therapies, Glucose Control and Incident Diabetes: Evidence, Mechanisms and Clinical Implications Barak ZafrirMohit Jain ORIGINAL ARTICLE 21 June 2014 Pages: 361 - 377
Biodegradable Polymer Drug-Eluting Stents Versus Second-Generation Drug-Eluting Stents for Patients With Coronary Artery Disease: An Update Meta-Analysis Yanyu WangPingshuan DongXiyan Shang ORIGINAL ARTICLE 20 May 2014 Pages: 379 - 385
Histogram and Vertical Bar diagram: Often Misapprehended Concept Mageshwaran Lakshmanan LETTER TO THE EDITOR Open access 13 June 2014 Pages: 387 - 387
Answer to: “Histogram and Vertical Bar Diagram: Often Misapprehended Concept” by M. Lakshmanan Jie Du LETTER TO THE EDITOR 13 June 2014 Pages: 389 - 389
NLRP3, a Potential Therapeutic Target for Type 2 Diabetes? Shan-Shan LiuYe DingJi-Quan Lou LETTER TO THE EDITOR 28 May 2014 Pages: 391 - 392